Recap: Paratek Pharmaceuticals Q1 Earnings

Paratek Pharmaceuticals PRTK reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Paratek Pharmaceuticals missed estimated earnings by 6.06%, reporting an EPS of $-0.35 versus an estimate of $-0.33.

Revenue was up $6.38 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.22 which was followed by a 4.05% increase in the share price the next day.

Here's a look at Paratek Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.09 -0.29 -0.34 -0.35
EPS Actual -0.13 -0.38 -0.33 -0.35
Revenue Estimate 63.45M 34.19M 29.17M 27.15M
Revenue Actual 75.60M 30.21M 29.64M 24.86M

To track all earnings releases for Paratek Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!